Partner Therapeutics competitors

Zippia score 4.2

Competitor Summary. See how Partner Therapeutics compares to its main competitors:

Global Blood Therapeutics has the most employees (457).
The oldest company is Nabriva Therapeutics, founded in 2006.

Work at Partner Therapeutics?

Share your experience

Partner Therapeutics vs competitors

Company	Founding date	Zippia score	Headquarters	# of Locations	Revenue	Employees
Partner Therapeutics	2017	4.2	Boston, MA	1	$7.8M	195
Nabriva Therapeutics	2006	4.1	San Diego, CA	1	$12.0M	175
Tarsa Therapeutics	2009	3.8	Philadelphia, PA	1	$1.6M	10
Edgewise Therapeutics	2017	4.0	Boulder, CO	1	$30,000	45
Axsome Therapeutics	2012	3.6	New York, NY	1	$385.7M	29
Global Blood Therapeutics	2011	4.5	South San Francisco, CA	2	$194.7M	457
Aurinia Pharmaceuticals	2013	4.4	-	1	$235.1M	33

Rate Partner Therapeutics' competitiveness in the market.

Partner Therapeutics salaries vs competitors

Compare Partner Therapeutics salaries vs competitors

Company	Average salary	Hourly salary	Salary score
Partner Therapeutics	$36,256	$17.43	-

Compare Partner Therapeutics job title salaries vs competitors

Company	Highest salary	Hourly salary
Partner Therapeutics	$36,218	$17.41
Axsome Therapeutics	$38,710	$18.61
Edgewise Therapeutics	$38,242	$18.39
Nabriva Therapeutics	$38,118	$18.33
Tarsa Therapeutics	$37,013	$17.79
Global Blood Therapeutics	$35,731	$17.18
Aurinia Pharmaceuticals	$34,712	$16.69

Do you work at Partner Therapeutics?

Is Partner Therapeutics able to compete effectively with similar companies?

Partner Therapeutics jobs

Partner Therapeutics and similar companies CEOs

CEOBio

Herriott Tabuteau

Axsome Therapeutics

Dr. Tabuteau has served as our founder, Chief Executive Officer, and Chairman of our board of directors since our founding in January 2012. Prior to founding our company, Dr. Tabuteau was a Senior Analyst and Partner at Healthco/S.A.C. Capital (now known as HealthCor) where he was responsible for the biotechnology, genomics, and instrumentation portfolios. Previously, Dr. Tabuteau was the healthcare analyst at Kingdon Capital. Prior to that position, Dr. Tabuteau was a Senior Research Analyst at Banc of America Securities covering the hospital supplies sector. Prior to Banc of America, Dr. Tabuteau was part of the healthcare investment banking group at Goldman Sachs. Dr. Tabuteau earned his M.D. from Yale University School of Medicine and his Bachelor of Arts in molecular biology and biochemistry from Wesleyan University.

Ted W. Love

Global Blood Therapeutics

Mr. Stephen Zaruby W.

Aurinia Pharmaceuticals

Mr. Stephen Zaruby W. is a President and Chief Executive Officer at AURINIA PHARMACEUTICALS INC and is based in United States.

Theodore R. Schroeder

Nabriva Therapeutics